The Lancet Makes Research More Accessible for Healthcare Professionals with New App for iPad

London, January 4, 2012 The Lancet, the world's leading independent general medical journal, today announced its first app for iPad is now available on the App Store. The Lancet App is an innovative article-based navigation app that makes it easier for healthcare professionals (HCPs) to find the information they need quickly and efficiently from the convenience of their iPad.

“In this new mobile and tablet age, you have to think about how a doctor seeks and uses the information they need,” explains Scott Virkler, SVP e-Products Global Medical Research, Elsevier Health Sciences. “iPad gave us the opportunity to rewrite the rules according to the needs of our readers and provide them a convenient solution. With this article-based navigation app, we’ve created an entirely new model that responds to our readers’ need to get to the articles they want, when they want."

The app gives subscribers convenient access to the latest articles published in The Lancet, The Lancet Oncology, The Lancet Neurology and The Lancet Infectious Diseases. Articles are sent to users and categorized by topic for an easy, at-a-glance overview. Users can annotate articles, share them with colleagues and create alerts and bookmark favorites. They can also search the journal database from the app and download articles for immediate or future use, either on or offline. 

The Lancet App is one of many apps Elsevier is developing for healthcare professionals. “We have an extensive, robust mobile app development program,” added Virkler. “Healthcare professionals are on the leading edge of this exciting new publishing medium."

The Lancet App is available for free from the App Store on iPad or at  www.itunes.com/appstore. Selected content is available for all viewers. Subscribers to The Lancent have access to all published content.


About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Tony Kirby
Media Relations Manager
The Lancet Press Office
32 Jamestown Road
Camden
London
NW1 7BY

Tel: +44 (0) 20 7424 4949
Mob: +44 (0) 7920 592635

E-mail: tony.kirby@lancet.com